Results 1 to 10 of about 2,228 (153)

Extracorporeal photopheresis as induction therapy in lung transplantation for cystic fibrosis: a pilot randomized trial [PDF]

Frontiers in Immunology
IntroductionExtracorporeal photopheresis (ECP) is a viable treatment that slows the progression of chronic lung allograft dysfunction. Despite its immunoregulatory potential, data on extracorporeal photopheresis as an induction therapy remain rather ...
Ilaria Righi, Claudio Fenizia, Daria Trabattoni, Mario Nosotti, Mario Nosotti, Giacomo Grisorio, Claudia Vanetti, Claudia Vanetti, Sonia di Tella, Cristina Mocellin, Norma Fantini, Daniele Prati, Letizia Corinna Morlacchi, Valeria Rossetti, Francesco Blasi, Francesco Blasi, Mario Clerici, Mario Clerici, Lorenzo Paolo Rosso, Lorenzo Paolo Rosso   +19 more
doaj   +2 more sources

Is a Functional Cure Possible in Autoimmune Diseases? Evidence from Trigger Eradication, Transplantation, and Cellular Therapies [PDF]

Rheumatology and Therapy
Introduction Traditionally considered incurable, autoimmune diseases (AIDs) may—in specific circumstances—achieve sustained remission or even a “functional cure,” defined as durable clinical and laboratory remission without immunosuppression. This review
Jozélio Freire de Carvalho, Carlos Ewerton Maia Rodrigues   +1 more
doaj   +2 more sources

Extracorporeal Photopheresis—An Overview

Frontiers in Medicine, 2018
Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of cutaneous T-cell lymphoma (CTCL) in 1988.
Ara Cho, Christian Jantschitsch, Robert Knobler   +2 more
doaj   +3 more sources

Extracorporeal Photopheresis Stimulates Tissue Repair after Transplantation [PDF]

Transplantation Direct
Extracorporeal photopheresis (ECP) is a safe and effective therapy with long-established indications in treating T cell–mediated immune diseases, including steroid refractory graft-versus-host disease and chronic rejection after heart or lung ...
Fabiola Arella, MSc, Hans J. Schlitt, MD, Paloma Riquelme, PhD   +2 more
doaj   +2 more sources

Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patients [PDF]

Frontiers in Immunology
BackgroundCheckpoint inhibition induced immune-related adverse events (irAE) may be steroid-dependent or steroid-refractory and are associated with increased morbidity, mortality and potentially compromised anti-tumor immunity.
Carl Maximilian Thielmann, Carl Maximilian Thielmann, Johanna Andrea Seier, Lisa Schielke, Lea Jessica Albrecht, Lisa Zimmer, Elisabeth Livingstone, Anne Zaremba, Anne Zaremba, Georg Lodde, Georg Lodde, Joachim Dissemond, Wiebke Sondermann, Frederik Krefting, Alpaslan Tasdogan, Alexander Roesch, Eva Hadaschik, Florian Rambow, Klaus Griewank, Selma Ugurel, Dirk Schadendorf, Dirk Schadendorf, Dirk Schadendorf, Jan-Malte Placke   +23 more
doaj   +2 more sources

Lower incidence of chronic graft-versus-host disease after ruxolitinib plus extracorporeal photopheresis versus ruxolitinib alone in steroid-refractory acute graft-versus-host disease following allogeneic stem cell transplantation [PDF]

Haematologica
We compared long-term outcomes in 78 patients with steroid-refractory acute graft-versushost disease (SR-aGVHD) treated at the University Medical Center Hamburg, Germany between December 2015 and August 2022 who received either ruxolitinib alone (Ruxo ...
Iryna Lastovytska, Silke Heidenreich, Evgeny Klyuchnikov, Christian Niederwieser, Nico Gagelmann, Johanna Richter, Radwan Massoud, Kristin Rathje, Tetiana Perekhrestenko, Gaby Zeck, Catherina Lück, Dietlinde Janson, Christine Wolschke, Francis Ayuk, Nicolaus Kröger   +14 more
doaj   +2 more sources

Use of Extracorporeal Photopheresis Treatment Over Time (2001–2023) in Alberta, Canada: A Retrospective Cohort Study [PDF]

Health Science Reports
Louis Girard, Sylvia Aponte‐Hao, Jason R. Randall, Karen J. B. Martins, Huong Luu, Khanh Vu, Tyler Williamson, Scott W. Klarenbach   +7 more
doaj   +2 more sources

Have no fear, IR is here: A case of right brachiocephalic vein /svc recanalization for port placement [PDF]

Radiology Case Reports
A patient with a history of cystic fibrosis and bilateral lung transplant presented internal jugular port placement for extracorporeal photopheresis in the setting of acute rejection.
Garrett DePalma, DO, Tomas Mujo, DO
doaj   +2 more sources

Treatment of graft versus host disease with photopheresis interferes in voriconazole therapeutic drug monitoring: A case study

Practical Laboratory Medicine, 2023
Extracorporeal photopheresis is an established procedure for refractory graft-versus-host disease, a major complication associated with notable morbidity and mortality in patients with allogeneic hematopoietic stem cell transplant.
Adriana Sassone, Juliana Testard, Andrea Saulo, Analia Julia, Paula Schaiquevich   +4 more
doaj   +1 more source

Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Patients with Chronic Graft-versus-Host Disease: A First-in-Human Study

Pharmaceutics, 2021
Extracorporeal photopheresis (ECP), an immunomodulatory therapy for the treatment of chronic graft-versus-host disease (cGvHD), exposes isolated white blood cells to photoactivatable 8-methoxypsoralen (8-MOP) and UVA light to induce the apoptosis of T ...
Eidi Christensen, Olav A. Foss, Petter Quist-Paulsen, Ingrid Staur, Frode Pettersen, Toril Holien, Petras Juzenas, Qian Peng   +7 more
doaj   +1 more source